Noile-Immune Biotech Inc. Financial Overview
Noile-Immune Biotech Inc.'s market cap is currently ¥5.97B. The company's EPS TTM is ¥-4.46; its P/E ratio is -7.30; Noile-Immune Biotech Inc. is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
